Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 22

1.

Quantitative Profiling of Platelet-Rich Plasma Indole Markers by Direct-Matrix Derivatization Combined with LC-MS/MS in Patients with Neuroendocrine Tumors.

van Faassen M, Bouma G, de Hosson LD, Peters MAM, Kats-Ugurlu G, de Vries EGE, Walenkamp AME, Kema IP.

Clin Chem. 2019 Nov;65(11):1388-1396. doi: 10.1373/clinchem.2019.305359. Epub 2019 Sep 24.

PMID:
31551315
2.

Adherence to pre-set benchmark quality criteria to qualify as expert assessor of dysplasia in Barrett's esophagus biopsies - towards digital review of Barrett's esophagus.

van der Wel MJ, Klaver E, Duits LC, Pouw RE, Seldenrijk CA, Offerhaus G, Visser M, Ten Kate F, Biermann K, Brosens L, Doukas M, Huysentruyt C, Karrenbeld A, Kats-Ugurlu G, van der Laan JS, van Lijnschoten G, Moll F, Ooms A, Tijssen JG, Bergman J, Meijer SL.

United European Gastroenterol J. 2019 Aug;7(7):889-896. doi: 10.1177/2050640619853441. Epub 2019 May 21.

3.

Reliability of clinical nodal status regarding response to neoadjuvant chemoradiotherapy compared with surgery alone and prognosis in esophageal cancer patients.

Dijksterhuis WPM, Hulshoff JB, van Dullemen HM, Kats-Ugurlu G, Burgerhof JGM, Korteweg T, Mul VEM, Hospers GAP, Plukker JTM.

Acta Oncol. 2019 Nov;58(11):1640-1647. doi: 10.1080/0284186X.2019.1648865. Epub 2019 Aug 9.

PMID:
31397195
4.

Comprehensive Profiling of Primary and Metastatic ccRCC Reveals a High Homology of the Metastases to a Subregion of the Primary Tumour.

Ferronika P, Hof J, Kats-Ugurlu G, Sijmons RH, Terpstra MM, de Lange K, Leliveld-Kors A, Westers H, Kok K.

Cancers (Basel). 2019 Jun 12;11(6). pii: E812. doi: 10.3390/cancers11060812.

5.

Reversal of secondary protein-losing enteropathy after surgical revision of a jejunal Roux-en-Y loop in a patient after liver transplantation.

Holvast A, Kats-Ugurlu G, Bodewes FAJA, de Kleine RHJ, Porte RJ, Brouwers AH, van der Doef HPJ.

Am J Transplant. 2019 Jul;19(7):2116-2121. doi: 10.1111/ajt.15354. Epub 2019 Apr 2.

PMID:
30868732
6.

ASO Author Reflections: Diagnostic Significance of Extramural Venous Invasion in Patients with Locally Advanced Esophageal Cancer.

Faiz Z, Kats-Ugurlu G, Plukker JTM.

Ann Surg Oncol. 2018 Dec;25(Suppl 3):962-963. doi: 10.1245/s10434-018-6985-5. Epub 2018 Oct 31. No abstract available.

7.

False-positive findings on 6-[18F]fluor-l-3,4-dihydroxyphenylalanine PET (18F-FDOPA-PET) performed for imaging of neuroendocrine tumors.

Berends AMA, Kerstens MN, Bolt JW, Links TP, Korpershoek E, de Krijger RR, Walenkamp AME, Noordzij W, van Etten B, Kats-Ugurlu G, Brouwers AH, van der Horst-Schrivers ANA.

Eur J Endocrinol. 2018 Aug;179(2):125-133. doi: 10.1530/EJE-18-0321. Epub 2018 Jun 6.

PMID:
29875288
8.

Prevalence and Prognostic Significance of Extramural Venous Invasion in Patients with Locally Advanced Esophageal Cancer.

Faiz Z, Huijgen LJW, Alqethami HJ, Burgerhof JGM, Kats-Ugurlu G, Plukker JTM.

Ann Surg Oncol. 2018 Jun;25(6):1588-1597. doi: 10.1245/s10434-018-6448-z. Epub 2018 Apr 2.

9.

Prediction of Response to Neoadjuvant Chemotherapy and Radiation Therapy with Baseline and Restaging 18F-FDG PET Imaging Biomarkers in Patients with Esophageal Cancer.

Beukinga RJ, Hulshoff JB, Mul VEM, Noordzij W, Kats-Ugurlu G, Slart RHJA, Plukker JTM.

Radiology. 2018 Jun;287(3):983-992. doi: 10.1148/radiol.2018172229. Epub 2018 Mar 14.

PMID:
29533721
10.

Improved diagnostic stratification of digitised Barrett's oesophagus biopsies by p53 immunohistochemical staining.

van der Wel MJ, Duits LC, Pouw RE, Seldenrijk CA, Offerhaus GJA, Visser M, Ten Kate FJ, Biermann K, Brosens LAA, Doukas M, Huysentruyt C, Karrenbeld A, Kats-Ugurlu G, van der Laan JS, van Lijnschoten GI, Moll FCP, Ooms AHAG, van der Valk H, Tijssen JG, Bergman JJ, Meijer SL.

Histopathology. 2018 May;72(6):1015-1023. doi: 10.1111/his.13462. Epub 2018 Feb 28.

PMID:
29314176
11.

Molecular fluorescence-guided surgery of peritoneal carcinomatosis of colorectal origin: a single-centre feasibility study.

Harlaar NJ, Koller M, de Jongh SJ, van Leeuwen BL, Hemmer PH, Kruijff S, van Ginkel RJ, Been LB, de Jong JS, Kats-Ugurlu G, Linssen MD, Jorritsma-Smit A, van Oosten M, Nagengast WB, Ntziachristos V, van Dam GM.

Lancet Gastroenterol Hepatol. 2016 Dec;1(4):283-290. doi: 10.1016/S2468-1253(16)30082-6. Epub 2016 Sep 17.

PMID:
28404198
12.

Predicting Response to Neoadjuvant Chemoradiotherapy in Esophageal Cancer with Textural Features Derived from Pretreatment 18F-FDG PET/CT Imaging.

Beukinga RJ, Hulshoff JB, van Dijk LV, Muijs CT, Burgerhof JGM, Kats-Ugurlu G, Slart RHJA, Slump CH, Mul VEM, Plukker JTM.

J Nucl Med. 2017 May;58(5):723-729. doi: 10.2967/jnumed.116.180299. Epub 2016 Oct 13.

13.

Niacin (Vitamin B3) Supplementation in Patients with Serotonin-Producing Neuroendocrine Tumor.

Bouma G, van Faassen M, Kats-Ugurlu G, de Vries EG, Kema IP, Walenkamp AM.

Neuroendocrinology. 2016;103(5):489-94. doi: 10.1159/000440621. Epub 2015 Sep 4.

PMID:
26335390
14.

Prognostic Value of the Circumferential Resection Margin in Esophageal Cancer Patients After Neoadjuvant Chemoradiotherapy.

Hulshoff JB, Faiz Z, Karrenbeld A, Kats-Ugurlu G, Burgerhof JG, Smit JK, Plukker JT.

Ann Surg Oncol. 2015 Dec;22 Suppl 3:S1301-9. doi: 10.1245/s10434-015-4827-2. Epub 2015 Aug 28.

15.

Consequence of restaging after neoadjuvant treatment for locally advanced rectal cancer.

Bisschop C, Tjalma JJ, Hospers GA, Van Geldere D, de Groot JW, Wiegman EM, Van't Veer-Ten Kate M, Havenith MG, Vecht J, Beukema JC, Kats-Ugurlu G, Mahesh SV, van Etten B, Havenga K, Burgerhof JG, de Groot DJ, de Vos Tot Nederveen Cappel WH.

Ann Surg Oncol. 2015 Feb;22(2):552-6. doi: 10.1245/s10434-014-3996-8. Epub 2014 Aug 26.

PMID:
25155395
16.

Neoadjuvant sorafenib treatment of clear cell renal cell carcinoma and release of circulating tumor fragments.

Kats-Ugurlu G, Oosterwijk E, Muselaers S, Oosterwijk-Wakka J, Hulsbergen-van de Kaa C, de Weijert M, van Krieken H, Desar I, van Herpen C, Maass C, de Waal R, Mulders P, Leenders W.

Neoplasia. 2014 Mar;16(3):221-8. doi: 10.1016/j.neo.2014.03.007. Epub 2014 Apr 13.

17.

[Massive rectal blood loss after colonoscopy].

Kampschreur MT, Kats-Ugurlu G, van Suylen RJ, De Schryver AM.

Ned Tijdschr Geneeskd. 2012;156(26):A4567. Dutch.

PMID:
22759709
18.

Better effect of sorafenib on the rhabdoid component of a clear cell renal cell carcinoma owing to its higher level of vascular endothelial growth factor-A production.

Kats-Ugurlu G, Maass C, van Herpen C, de Waal R, Oosterwijk E, Mulders P, Hulsbergen-van de Kaa C, Leenders W.

Histopathology. 2011 Sep;59(3):562-4. doi: 10.1111/j.1365-2559.2011.03923.x. No abstract available.

PMID:
22034894
19.

Splenic gas as a result of a non-Hodgkin's lymphoma in a patient with common variable immunodeficiency.

Croles FN, Hebeda KM, Kats-Ugurlu G, Hermans JJ, Bonenkamp HJ, van der Velden WJ.

J Clin Oncol. 2011 Aug 10;29(23):e666-7. doi: 10.1200/JCO.2011.35.6659. Epub 2011 Jun 6. No abstract available.

PMID:
21646607
20.

Diagnosis of alpha-1-antitrypsin deficiency in bleeding disorder-related neonatal death.

Kats-Ugurlu G, Hogeveen M, Driessen A, van den Ouweland AM, Hulsbergen-van de Kaa C.

Eur J Pediatr. 2011 Jan;170(1):103-6. doi: 10.1007/s00431-010-1280-x. Epub 2010 Sep 2.

21.

Effect of tyrosine kinase inhibitor treatment of renal cell carcinoma on the accumulation of carbonic anhydrase IX-specific chimeric monoclonal antibody cG250.

Oosterwijk-Wakka JC, Kats-Ugurlu G, Leenders WP, Kiemeney LA, Old LJ, Mulders PF, Oosterwijk E.

BJU Int. 2011 Jan;107(1):118-25. doi: 10.1111/j.1464-410X.2010.09314.x.

22.

Circulating tumour tissue fragments in patients with pulmonary metastasis of clear cell renal cell carcinoma.

Kats-Ugurlu G, Roodink I, de Weijert M, Tiemessen D, Maass C, Verrijp K, van der Laak J, de Waal R, Mulders P, Oosterwijk E, Leenders W.

J Pathol. 2009 Nov;219(3):287-93. doi: 10.1002/path.2613.

PMID:
19731255

Supplemental Content

Loading ...
Support Center